vs

Side-by-side financial comparison of EnerSys (ENS) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

EnerSys is the larger business by last-quarter revenue ($919.1M vs $493.8M, roughly 1.9× Pediatrix Medical Group, Inc.). EnerSys runs the higher net margin — 9.8% vs 6.8%, a 3.0% gap on every dollar of revenue. On growth, EnerSys posted the faster year-over-year revenue change (1.4% vs -1.7%). Over the past eight quarters, EnerSys's revenue compounded faster (0.5% CAGR vs -0.1%).

EnerSys is a stored energy systems and technology provider for industrial applications. The company manufactures reserve-power and motive-power batteries, battery chargers, power equipment, battery accessories and outdoor equipment enclosures.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

ENS vs MD — Head-to-Head

Bigger by revenue
ENS
ENS
1.9× larger
ENS
$919.1M
$493.8M
MD
Growing faster (revenue YoY)
ENS
ENS
+3.1% gap
ENS
1.4%
-1.7%
MD
Higher net margin
ENS
ENS
3.0% more per $
ENS
9.8%
6.8%
MD
Faster 2-yr revenue CAGR
ENS
ENS
Annualised
ENS
0.5%
-0.1%
MD

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ENS
ENS
MD
MD
Revenue
$919.1M
$493.8M
Net Profit
$90.4M
$33.7M
Gross Margin
30.1%
Operating Margin
13.5%
9.9%
Net Margin
9.8%
6.8%
Revenue YoY
1.4%
-1.7%
Net Profit YoY
-21.3%
10.5%
EPS (diluted)
$2.40
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENS
ENS
MD
MD
Q4 25
$919.1M
$493.8M
Q3 25
$951.3M
$492.9M
Q2 25
$893.0M
$468.8M
Q1 25
$974.8M
$458.4M
Q4 24
$906.2M
$502.4M
Q3 24
$883.7M
$511.2M
Q2 24
$852.9M
$504.3M
Q1 24
$910.7M
$495.1M
Net Profit
ENS
ENS
MD
MD
Q4 25
$90.4M
$33.7M
Q3 25
$68.4M
$71.7M
Q2 25
$57.5M
$39.3M
Q1 25
$96.5M
$20.7M
Q4 24
$114.8M
$30.5M
Q3 24
$82.3M
$19.4M
Q2 24
$70.1M
$-153.0M
Q1 24
$60.9M
$4.0M
Gross Margin
ENS
ENS
MD
MD
Q4 25
30.1%
Q3 25
29.1%
Q2 25
28.4%
Q1 25
31.2%
Q4 24
32.9%
Q3 24
28.5%
Q2 24
27.9%
Q1 24
27.9%
Operating Margin
ENS
ENS
MD
MD
Q4 25
13.5%
9.9%
Q3 25
9.7%
13.8%
Q2 25
9.7%
12.8%
Q1 25
13.5%
7.0%
Q4 24
15.7%
7.8%
Q3 24
11.2%
6.6%
Q2 24
10.7%
-31.3%
Q1 24
8.9%
3.2%
Net Margin
ENS
ENS
MD
MD
Q4 25
9.8%
6.8%
Q3 25
7.2%
14.5%
Q2 25
6.4%
8.4%
Q1 25
9.9%
4.5%
Q4 24
12.7%
6.1%
Q3 24
9.3%
3.8%
Q2 24
8.2%
-30.3%
Q1 24
6.7%
0.8%
EPS (diluted)
ENS
ENS
MD
MD
Q4 25
$2.40
$0.40
Q3 25
$1.80
$0.84
Q2 25
$1.46
$0.46
Q1 25
$2.39
$0.24
Q4 24
$2.88
$0.37
Q3 24
$2.01
$0.23
Q2 24
$1.71
$-1.84
Q1 24
$1.48
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENS
ENS
MD
MD
Cash + ST InvestmentsLiquidity on hand
$450.1M
$375.2M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$1.9B
$865.9M
Total Assets
$4.0B
$2.2B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENS
ENS
MD
MD
Q4 25
$450.1M
$375.2M
Q3 25
$388.6M
$340.1M
Q2 25
$346.7M
$224.7M
Q1 25
$343.1M
$99.0M
Q4 24
$463.2M
$229.9M
Q3 24
$407.9M
$103.8M
Q2 24
$344.1M
$19.4M
Q1 24
$333.3M
$8.0M
Total Debt
ENS
ENS
MD
MD
Q4 25
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$1.1B
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Q1 24
$802.0M
Stockholders' Equity
ENS
ENS
MD
MD
Q4 25
$1.9B
$865.9M
Q3 25
$1.9B
$890.7M
Q2 25
$1.9B
$833.8M
Q1 25
$1.9B
$789.2M
Q4 24
$1.8B
$764.9M
Q3 24
$1.8B
$732.5M
Q2 24
$1.8B
$706.5M
Q1 24
$1.8B
$856.2M
Total Assets
ENS
ENS
MD
MD
Q4 25
$4.0B
$2.2B
Q3 25
$4.1B
$2.2B
Q2 25
$4.1B
$2.1B
Q1 25
$4.0B
$2.0B
Q4 24
$4.0B
$2.2B
Q3 24
$4.0B
$2.1B
Q2 24
$3.6B
$2.0B
Q1 24
$3.5B
$2.2B
Debt / Equity
ENS
ENS
MD
MD
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.57×
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENS
ENS
MD
MD
Operating Cash FlowLast quarter
$184.6M
$114.1M
Free Cash FlowOCF − Capex
$171.3M
FCF MarginFCF / Revenue
18.6%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
2.04×
3.39×
TTM Free Cash FlowTrailing 4 quarters
$441.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENS
ENS
MD
MD
Q4 25
$184.6M
$114.1M
Q3 25
$218.0M
$137.3M
Q2 25
$968.0K
$137.2M
Q1 25
$135.2M
$-117.5M
Q4 24
$81.1M
$133.0M
Q3 24
$33.6M
$91.8M
Q2 24
$10.4M
$107.0M
Q1 24
$-125.2M
Free Cash Flow
ENS
ENS
MD
MD
Q4 25
$171.3M
Q3 25
$197.1M
Q2 25
$-32.1M
Q1 25
$104.9M
Q4 24
$56.8M
Q3 24
$3.3M
Q2 24
$-25.7M
Q1 24
FCF Margin
ENS
ENS
MD
MD
Q4 25
18.6%
Q3 25
20.7%
Q2 25
-3.6%
Q1 25
10.8%
Q4 24
6.3%
Q3 24
0.4%
Q2 24
-3.0%
Q1 24
Capex Intensity
ENS
ENS
MD
MD
Q4 25
1.4%
Q3 25
2.2%
Q2 25
3.7%
Q1 25
3.1%
Q4 24
2.7%
Q3 24
3.4%
Q2 24
4.2%
Q1 24
Cash Conversion
ENS
ENS
MD
MD
Q4 25
2.04×
3.39×
Q3 25
3.19×
1.91×
Q2 25
0.02×
3.49×
Q1 25
1.40×
-5.66×
Q4 24
0.71×
4.36×
Q3 24
0.41×
4.72×
Q2 24
0.15×
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENS
ENS

Energy Systems$399.5M43%
Motive Power$352.0M38%
Services$92.6M10%
Transferred Over Time$38.2M4%
Other$36.8M4%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons